Viewing Study NCT00865904

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2026-03-31 @ 10:37 PM
Study NCT ID: NCT00865904
Status: COMPLETED
Last Update Posted: 2015-08-28
First Post: 2009-03-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystic Fibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ∆F508 View
None F508del View
None Cystic Fibrosis Transmembrane Conductance Regulator View
None CFTR View
None Pancreatic diseases View
None Lung diseases View
None Genetic disease, inborn View
None Infant, newborn, diseases View